Latest stories on ORIC
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
StockTitan50 · neutralgeneral
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire50 · neutralgeneral
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Business Insider50 · neutralgeneral
Himalayas-1: Bayer and ORIC Double Down on Prostate Cancer With New Phase 3 Combo Trial
TipRanks67 · bullishproduct/pr
ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences
Business Insider56 · neutralgeneral
ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences
GlobeNewswire56 · neutralgeneral
H.C. Wainwright raises ORIC Pharmaceuticals price target to $27 on pipeline progress
Investing.com Analyst Ratings61 · neutralanalyst
Oric Pharmaceuticals Price Target Raised To 27 From 25 At H C Wainwright
The Fly61 · neutralanalyst
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Business Insider50 · neutralgeneral
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
StockTitan50 · neutralgeneral
ORIC Pharmaceuticals GAAP EPS of -$0.38 misses by $0.02
Seeking Alpha34 · bearishearnings
Oric Pharmaceuticals, Inc. (ORIC) files 8-K
SEC 8-K50 · neutralgeneral
ORIC® Pharmaceuticals Reports Second Quarter 2026 Financial Results and Operational Updates
Business Insider56 · neutralgeneral
Oric Pharmaceuticals Expands Inducement Equity Incentive Plan
TipRanks50 · neutralgeneral
Oric Pharmaceuticals, Inc. (ORIC) files 8-K
SEC 8-K50 · neutralgeneral
ORIC Pharmaceuticals: Royalty-Free Phase 3 Economics Strengthen The Bull Case
Seeking Alpha67 · bullishproduct/pr
ORIC® Pharmaceuticals Announces Three Presentations at the European Society for Medical Oncology (ESMO) Congress 2026
StockTitan63 · neutralproduct/pr
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | ORIC Stock News
StockTitan50 · neutralgeneral
Oric Pharmaceuticals, Inc. (ORIC) files 8-K
SEC 8-K50 · neutralgeneral
ORIC gains as Stifel resumes at Buy on upcoming Pfizer readout
Seeking Alpha63 · neutralanalyst
ORIC Pharmaceuticals, Inc. (ORIC) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Seeking Alpha56 · neutralgeneral
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | ORIC Stock News
StockTitan50 · neutralgeneral
ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences | ORIC Stock News
StockTitan56 · neutralgeneral